Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

A sharp rally is drawing attention after Morgan Stanley reiterated a bullish view and SpaceXs proposed Florida methane pipeline for Starship highlighted plans to support more launches; traders also point to the upcoming Starship flight and the companys AI and chipmaking ambitions. Bulls emphasize growth potential and momentum, while skeptics question the valuation and warn that share unlocks could add selling pressure.

Novavaxs sharp rally is being linked by traders to Russian plague-outbreak headlines and renewed pandemic-vaccine speculation, though some argue the outbreak has no direct connection to the company and may be only a partial catalyst. The move has fueled short-squeeze chatter around NVAXs high short interest, while other traders point to Sanofi and Takedas Nuvaxovid commercialization as a more durable factor.

GRRR is drawing attention amid continued share-price weakness and uncertainty over how it will finance its large AI data-center projects, with traders concerned about dilution, execution and management credibility. Bulls cite the contract backlog and planned GPU deployments, while skeptics want concrete financing details and evidence that projects are converting into revenue and cash flow.

AAOIs reported completion of its at-the-market share sale is prompting relief buying as traders see the end of ongoing dilution as easing an overhang on the stock. Bullish discussion also points to AI data-center optics demand, while some remain wary of renewed share sales and the stocks sharp volatility.

Capricors 24-month HOPE-3 extension data showing slower upper-limb decline after patients switched to deramiocel has renewed focus on its Duchenne muscular dystrophy therapy and the pending FDA review. Despite the encouraging results, shares have fallen as traders weigh prior statistical concerns and analyst warnings of a possible rejection against hopes for approval; some attribute the decline to short-selling, but that remains speculation.

Evernorths shareholder-approved merger with Armada and its planned XRP-treasury business are driving attention, with traders focused on the forthcoming Nasdaq debut and the companys large XRP holdings. The stocks sharp, volatile run has fueled low-float squeeze and warrant-arbitrage speculation, while bears argue its valuation is far above the value of its XRP assets and warn of a pullback.

A reported roughly $4 billion federal loan to fund upgrades at Vistras nuclear plants is driving attention, alongside the broader view that AI and data-center growth is increasing demand for power. Traders are largely bullish on the potential capacity boost, but debate the stocks volatile, often fading price action and whether the reported financing will translate into near-term gains.

MercadoLibre is rallying alongside Brazilian and Latin American stocks after election results strengthened traders expectations of a more pro-business political direction in Brazil. The community largely attributes the move to regional political sentiment rather than company-specific news, while some question whether the election alone justifies the jump.

Constellations 20-year Amazon power agreement, including plans to add nuclear capacity at Calvert Cliffs, is drawing attention alongside the broader view that AI data centers are driving demand for reliable electricity. Traders see the deal as support for CEGs long-term growth, though some are frustrated that positive news has not consistently translated into stronger share performance.

Vaxcytes VAX-31 met the primary goals in its pivotal Phase 3 adult pneumococcal-vaccine trial, driving a sharp rally and optimism about its potential to compete with Pfizer and Merck vaccines. Traders are also debating whether to take profits after the surge and flagging dilution concerns around the companys proposed offerings.